1. Treatment with the cystic fibrosis transmembrane conductance regulator (CFTR) protein corrector VX-659 in combination with tezacaftor–ivacaftor significantly improved measures...

1. Among patients with septic shock and acute kidney injury (AKI), there was no significant difference in 90-day mortality between...

1. Patients with an acute myocardial infarction (MI) and ejection fraction less than 35% did not have reduced incidence of...

1. During one month at a single medical center in Illinois in 2018, 34 cases of synthetic cannabinoid associated coagulopathy...

1. At a median follow-up of 3.3 years, rates of composite cardiovascular events in at-risk overweight or obese patients treated...

1. At a median follow-up of 3.3 years, rates of symptomatic venous thromboembolism or death due to thromboembolism were similar...

1. In a phase 3 randomized control trial, tafamidis was shown to have associations with greater reductions in all-cause mortality...

1. The antiviral agent baloxavir (baloxavir marboxil) decreased duration of influenza symptoms significantly more than in patients treated with either...

1. Patients with stable chest pain referred to a cardiology clinic who received standard care plus coronary CT angiography (CTA)...

1. Among dengue-seronegative individuals 2 to 16 years of age, there was a significantly increased risk of hospitalization and severe...